Home » Topics » Regulatory » Patents

Patents
RSS

AMMS synthesizes new adenosine A2A receptor agonists

Jan. 11, 2021

Indian researchers patent new lipoxygenase inhibitors

Jan. 11, 2021

Calithera Biosciences presents CD73 inhibitors

Jan. 11, 2021

Bristol Myers Squibb discloses new FPR2 agonists

Jan. 11, 2021

Dana-Farber Cancer Institute patents EGFR allosteric inhibitors

Jan. 11, 2021

BioWorld MedTech Patent Highlights: Week 53

From Current Patent Gazette

Jan. 8, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

ViiV Healthcare discovers compounds for HIV infection

Jan. 8, 2021

Pfizer and CTxT Pty synthesize KAT inhibitors

Jan. 8, 2021

GlaxoSmithKline plc discloses new antibacterials

Jan. 8, 2021

Chinese researchers presents new SERCAs for breast cancer

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...